Emi Kimoto

Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions

Maria Karlgren, Anna Vildhede, Ulf Norinder et al. · Journal of Medicinal Chemistry · 2012 · 358 citations · Full text

Transport Kinetics, Medicinal Chemistry, Drug Target +15

Lower risk for cardiovascular mortality in oral 1 -hydroxy vitamin D3 users in a haemodialysis population

Takahiro Shoji, K. Shinohara, Emi Kimoto et al. · Nephrology Dialysis Transplantation · 2003 · 351 citations · Full text

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

Britton Boras, Rhys Jones, Brandon J. Anson et al. · Nature Communications · 2021 · 284 citations · Full text

Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data

Hannah M. Jones, Hugh A. Barton, Yurong Lai et al. · Drug Metabolism and Disposition · 2012 · 241 citations

Body fat mass and lean mass as predictors of survival in hemodialysis patients

Ryusuke Kakiya, Tetsuo Shoji, Yoshihiro Tsujimoto et al. · Kidney International · 2006 · 168 citations

Obesity, Metabolic Syndrome, Hemodialysis +11